We are delighted to share some of the highly cited papers from the Section “Lipid Metabolism” that were published in Metabolites (ISSN: 2218-1989) from 2023 to 2024. The following is a list of high-quality articles and Special Issues that we believe will be of interest to you:

1. “High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity”
by Damien Denimal, Serge Monier, Benjamin Bouillet, Bruno Vergès and Laurence Duvillard
Metabolites 2023, 13(2), 253; https://doi.org/10.3390/metabo13020253
Available online: https://www.mdpi.com/2218-1989/13/2/253

2. “Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance”
by Amnah Al-Sayyar, Maha M. Hammad, Michayla R. Williams, Mohammed Al-Onaizi, Jehad Abubaker and Fawaz Alzaid
Metabolites 2023, 13(3), 384; https://doi.org/10.3390/metabo13030384
Available online: https://www.mdpi.com/2218-1989/13/3/384

3. “Atherosclerosis Calcification: Focus on Lipoproteins”
by Jaap G. Neels, Georges Leftheriotis and Giulia Chinetti
Metabolites 2023, 13(3), 457; https://doi.org/10.3390/metabo13030457
Available online: https://www.mdpi.com/2218-1989/13/3/457

4. “Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target”
by Allison B. Reiss, Saba Ahmed, Maryann Johnson, Usman Saeedullah and Joshua De Leon
Metabolites 2023, 13(4), 479; https://doi.org/10.3390/metabo13040479
Available online: https://www.mdpi.com/2218-1989/13/4/479

5. “Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options”
by Bilal Bashir, Jan H. Ho, Paul Downie, Paul Hamilton, Gordon Ferns, Dev Datta, Jaimini Cegla, Anthony S. Wierzbicki, Charlotte Dawson, Fiona Jenkinson et al.
Metabolites 2023, 13(5), 621; https://doi.org/10.3390/metabo13050621
Available online: https://www.mdpi.com/2218-1989/13/5/621

6. “The Integration of Metabolomics, Electronic Tongue, and Chromatic Difference Reveals the Correlations between the Critical Compounds and Flavor Characteristics of Two Grades of High-Quality Dianhong Congou Black Tea”
by Shan Zhang, Xujiang Shan, Linchi Niu, Le Chen, Jinjin Wang, Qinghua Zhou, Haibo Yuan, Jia Li and Tian Wu
Metabolites 2023, 13(7), 864; https://doi.org/10.3390/metabo13070864
Available online: https://www.mdpi.com/2218-1989/13/7/864

7. “Porokeratoses—A Comprehensive Review on the Genetics and Metabolomics, Imaging Methods and Management of Common Clinical Variants”
by Paweł Pietkiewicz, Katarzyna Korecka, Natalia Salwowska, Ihor Kohut, Adarsha Adhikari, Monika Bowszyc-Dmochowska, Anna Pogorzelska-Antkowiak and Cristian Navarrete-Dechent
Metabolites 2023, 13(12), 1176; https://doi.org/10.3390/metabo13121176
Available online: https://www.mdpi.com/2218-1989/13/12/1176

8. “Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD)”
by Majid Mufaqam Syed-Abdul
Metabolites 2024, 14(1), 12; https://doi.org/10.3390/metabo14010012
Available online: https://www.mdpi.com/2218-1989/14/1/12

9. “ApoB100 and Atherosclerosis: What’s New in the 21st Century?”
by Dimitris Kounatidis, Natalia G. Vallianou, Aikaterini Poulaki, Angelos Evangelopoulos, Fotis Panagopoulos, Theodora Stratigou, Eleni Geladari, Irene Karampela and Maria Dalamaga
Metabolites 2024, 14(2), 123; https://doi.org/10.3390/metabo14020123
Available online: https://www.mdpi.com/2218-1989/14/2/123

10. “Lipidome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys with Metabolic Dysfunction-Associated Steatotic Liver Disease”
by Helaina E. Huneault, Chih-Yu Chen, Catherine C. Cohen, Xueyun Liu, Zachery R. Jarrell, Zhulin He, Karla E. DeSantos, Jean A. Welsh, Kristal M. Maner-Smith, Eric A. Ortlund et al.
Metabolites 2024, 14(4), 191; https://doi.org/10.3390/metabo14040191
Available online: https://www.mdpi.com/2218-1989/14/4/191

11. “Comparative Lipidomics of Oral Commensal and Opportunistic Bacteria”
by Paul L. Wood, Annie Le and Dominic L. Palazzolo
Metabolites 2024, 14(4), 240; https://doi.org/10.3390/metabo14040240
Available online: https://www.mdpi.com/2218-1989/14/4/240

12. “Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies”
by Chiara Sanluca, Paolo Spagnolo, Romina Mancinelli, Maria Ilenia De Bartolo, Marina Fava, Mauro Maccarrone, Simone Carotti, Eugenio Gaudio, Alessandro Leuti and Giorgio Vivacqua
Metabolites 2024, 14(7), 352; https://doi.org/10.3390/metabo14070352
Available online: https://www.mdpi.com/2218-1989/14/7/352